Knoll Capital Management as of Sept. 30, 2020
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 30 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 45.7 | $56M | 858k | 65.01 | |
| Applied Therapeutics (APLT) | 12.5 | $15M | 735k | 20.76 | |
| Corbus Pharmaceuticals Hldgs | 7.4 | $9.1M | 5.0M | 1.80 | |
| Orgenesis | 5.4 | $6.6M | 1.3M | 5.04 | |
| Eiger Biopharmaceuticals | 4.0 | $4.8M | 595k | 8.14 | |
| Aldeyra Therapeutics (ALDX) | 3.5 | $4.2M | 569k | 7.41 | |
| Abeona Therapeutics | 2.4 | $2.9M | 2.9M | 1.02 | |
| Anavex Life Sciences Corp Com New (AVXL) | 2.3 | $2.8M | 621k | 4.55 | |
| Exicure | 1.8 | $2.2M | 1.3M | 1.75 | |
| CenturyLink | 1.8 | $2.2M | 220k | 10.09 | |
| Entera Bio SHS (ENTX) | 1.8 | $2.2M | 1.7M | 1.24 | |
| Blackstone Group Com Unit Ltd | 1.7 | $2.1M | 40k | 52.20 | |
| Dow (DOW) | 1.2 | $1.4M | 30k | 47.20 | |
| Soligenix | 1.2 | $1.4M | 788k | 1.79 | |
| Molecular Templates | 1.0 | $1.2M | 114k | 10.92 | |
| Bioxcel Therapeutics (BTAI) | 0.7 | $867k | 20k | 43.35 | |
| Corteva (CTVA) | 0.7 | $864k | 30k | 28.80 | |
| Dupont De Nemours (DD) | 0.7 | $832k | 15k | 55.47 | |
| Seabridge Gold (SA) | 0.5 | $601k | 32k | 18.78 | |
| Maverix Metals Com New | 0.5 | $591k | 115k | 5.14 | |
| Agnico (AEM) | 0.4 | $549k | 6.9k | 79.57 | |
| Equinox Gold Corp equities (EQX) | 0.4 | $533k | 46k | 11.71 | |
| Kirkland Lake Gold | 0.4 | $524k | 11k | 48.74 | |
| Franco-Nevada Corporation (FNV) | 0.4 | $523k | 3.8k | 139.47 | |
| Osisko Gold Royalties (OR) | 0.4 | $496k | 190k | 2.61 | |
| Mag Silver Corp (MAG) | 0.2 | $281k | 17k | 16.24 | |
| Fortuna Silver Mines | 0.2 | $278k | 44k | 6.36 | |
| Silvercorp Metals (SVM) | 0.2 | $264k | 37k | 7.23 | |
| Pan American Silver Corp Can (PAAS) | 0.2 | $264k | 8.2k | 32.20 | |
| Silvercrest Metals (SILV) | 0.2 | $263k | 31k | 8.48 |
